DrPUGAZHENTHAN THANGARAJU
RESEARCH INTERESTS
Dr. Pugazhenthan Thangaraju’s research spans across clinical pharmacology, infectious disease management, and public health data analysis. His work is noted for bridging the gap between laboratory findings and practical patient care. [1, 2]
His primary research interests include:
1. Infectious Diseases (Leprosy focus) [3]
Dr. Thangaraju has extensive experience in the clinical division of the Central Leprosy Teaching and Research Institute. His research involves: [4, 5]
- Lepra Reactions: Studying the pharmacological management of reactions in leprosy patients.
- Drug Repurposing: Exploring the potential of anti-viral drugs (like Tenofovir) against Mycobacterium leprae using molecular docking. [6, 7]
His work at AIIMS Raipur focuses on the rational use of drugs and safety frameworks: [8, 9]
- Pharmacovigilance: Developing frameworks for monitoring adverse drug reactions (ADRs) to improve patient safety.
- Antimicrobial Resistance (AMR): Investigating antibiotic prescribing behaviours and raising awareness about AMR among physicians.
- Pharmacogenetics: Researching how genetic variations affect individual responses to drugs. [3, 5, 9, 10, 11]
As a specialist with a diploma in Diabetology, his research covers:
- Diabetes Mellitus: Management strategies and pharmacological interventions for diabetes and its complications, such as diabetic neuropathy. [12, 13]
He is a frequent collaborator on large-scale systematic analyses published in journals like The Lancet. These studies quantify the global impact of: [14, 15, 16, 17]
- Chronic Conditions: Asthma, atopic dermatitis, epilepsy, and obesity.
- Infectious Causes: Mortality and morbidity related to meningitis and lower respiratory infections. [14, 15, 18, 19, 20]
Dr. Thangaraju also explores the intersection of health and technology, such as developing ergonomic solutions for "tech neck" through smart wearable devices. [21]